Torres-Bonilla Gisela MD - Riverview, Florida 33579

Torres-Bonilla Gisela MD is categorized under Doctors in Riverview, FL .

Business Name: Torres-Bonilla Gisela MD
Contact Person: Gisela Torres-Bonilla
Address: 13142 Elk Mountain Drive, Riverview, Florida 33579
Phone Number: (813) 445-6076
Website Address: ecdss.com
Annual Revenue (USD): $500.000 to $999.999
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Doctors
SIC Code: 8011
NAICS Code: 6211110
Share This Business:
Related Businesses: Gullapalli Satya MD - Riverview, FL 33579
Kalik Craig A MD - Riverview, FL 33579
Augustin J MD - Riverview, FL 33579
Pae Suzan S MD - Riverview, FL 33579
Romagnolo Stephen C MD - Riverview, FL 33579
Proper Steven A MD - Riverview, FL 33579
Shulstad Raymond MD - Riverview, FL 33579
Partners in Allergy & Asthma - Riverview, FL 33579
Cynthia A Dreier & Affiliates - Riverview, FL 33579
National Mds Solutions - Riverview, FL 33579
Tower Radiology Center Riverview - Riverview, FL 33579
Boyett Walk in - Riverview, FL 33579
Mosquera Gonzalo MD - Riverview, FL 33579
Sue Wah Sing Cecil MD - Riverview, FL 33579
Smith Anne MD - Riverview, FL 33579
Bueno Jocelyn MD - Riverview, FL 33579
Ayala Raul MD - Riverview, FL 33579

The company Torres-Bonilla Gisela MD provides B2C services in the form of Doctors from its single location in Florida. 1 to 4 employees work for Torres-Bonilla Gisela MD, and the business now earns $500.000 to $999.999 per annum.

Torres-Bonilla Gisela MD was launched in 0 and is classified under SIC code and category 8011 , and NAICS number and grouping 6211110 . To contact Torres-Bonilla Gisela MD, please call Gisela Torres-Bonilla with the phone number (813) 445-6076 or visit its single location at 13142 Elk Mountain Drive in Riverview, Florida 33579.

The location of the single location can also be found using the coordinates 27.79364,-82.33025. Read more details about this business on the webpage ecdss.com or follow the company’s social media accounts, on Twitter and on Facebook.